ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Mustang Bio Inc

Mustang Bio Inc (MBIO)

0.1678
0.0027
(1.64%)
Cerrado 22 Diciembre 3:00PM
0.1796
0.0118
(7.03%)
Fuera de horario: 6:52PM

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
0.1796
Postura de Compra
0.1715
Postura de Venta
0.1799
Volume Operado de la Acción
898,722
0.1652 Rango del Día 0.1749
0.1281 Rango de 52 semanas 1.53
Capitalización de Mercado [m]
Precio Anterior
0.1651
Precio de Apertura
0.1668
Última hora de negociación
Volumen financiero
US$ 151,965
Precio Promedio Ponderado
0.169091
Volumen promedio (3 m)
1,909,457
Acciones en circulación
47,780,248
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.16
Beneficio por acción (BPA)
-1.08
turnover
-
Beneficio neto
-51.6M

Acerca de Mustang Bio Inc

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for ... Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies and CAR T therapies for solid tumors. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
Dover, Delaware, USA
Fundado
-
Mustang Bio Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MBIO. The last closing price for Mustang Bio was US$0.17. Over the last year, Mustang Bio shares have traded in a share price range of US$ 0.1281 to US$ 1.53.

Mustang Bio currently has 47,780,248 shares in issue. The market capitalisation of Mustang Bio is US$7.89 million. Mustang Bio has a price to earnings ratio (PE ratio) of -0.16.

MBIO Últimas noticias

Mustang Bio Receives Positive Listing Determination from Nasdaq

WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s...

Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma

MB-108 (HSV-1 oncolytic virus) is active and well tolerated in patients with recurrent glioblastoma in ongoing Phase 1 clinical trial Preclinical data support a novel combination of MB-108 (HSV-1...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.0204-10.20.20.20440.15398273970.17561327CS
4-0.0234-11.52709359610.2030.21670.15396401460.18817153CS
12-0.0699-28.01603206410.24950.37010.153919094570.27344508CS
26-0.3904-68.49122807020.570.85880.153930773890.41715506CS
52-1.1904-86.89051094891.371.530.128180123980.65037867CS
156-27.1204-99.342124542127.329.550.128129843941.82459664CS
260-49.7704-99.640440440449.9578.30.1281237956614.08025168CS

MBIO - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Mustang Bio?
El precio actual de las acciones de Mustang Bio es US$ 0.1796
¿Cuántas acciones de Mustang Bio están en circulación?
Mustang Bio tiene 47,780,248 acciones en circulación
¿Cuál es la capitalización de mercado de Mustang Bio?
La capitalización de mercado de Mustang Bio es USD 7.89M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Mustang Bio?
Mustang Bio ha negociado en un rango de US$ 0.1281 a US$ 1.53 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Mustang Bio?
El ratio precio/beneficio de Mustang Bio es -0.16
¿Cuál es la moneda de reporte de Mustang Bio?
Mustang Bio presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de Mustang Bio?
El último beneficio anual de Mustang Bio es USD -51.6M
¿Cuál es la dirección registrada de Mustang Bio?
La dirección registrada de Mustang Bio es 3500 SOUTH DUPONT HIGHWAY, DOVER, DELAWARE, 19901
¿Cuál es la dirección del sitio web de Mustang Bio?
La dirección del sitio web de Mustang Bio es www.mustangbio.com
¿En qué sector industrial opera Mustang Bio?
Mustang Bio opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
MYSZMy Size Inc
US$ 4.2001
(211.12%)
121.03M
NVNINVNI Group Ltd
US$ 8.26
(209.36%)
78.06M
TPICTPI Composites Inc
US$ 2.45
(100.82%)
34M
ICGIntchains Group Ltd
US$ 8.77
(88.60%)
527.94k
HSDTHelius Medical Technologies Inc
US$ 0.884851
(84.34%)
121.95M
CYNCYNGN Inc
US$ 0.4603
(-71.41%)
27.5M
MTEMMolecular Templates Inc
US$ 0.1502
(-57.09%)
8.63M
PRFXPainReform Ltd
US$ 5.15
(-53.85%)
2.84M
GALTGalectin Therapeutics Inc
US$ 1.03
(-48.50%)
8.58M
BCABBioAtla Inc
US$ 0.6923
(-41.82%)
5.96M
EDBLEdible Garden AG Inc
US$ 0.24
(65.06%)
354.33M
NVDANVIDIA Corporation
US$ 134.70
(3.08%)
310.19M
APTOAptose Biosciences Inc
US$ 0.28
(64.51%)
306.25M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.606999
(6.49%)
293.22M
PLTRPalantir Technologies Inc
US$ 80.55
(8.54%)
281.23M

MBIO Discussion

Ver más
georgie18 georgie18 3 semanas hace
MBIO....1989...Been accumulating from .10 /30 range...🥳

georgie18

Member Level
Re: georgie18 post# 209

Tuesday, November 12, 2024 8:37:06 AM

Post#
210
of 210
MBIO...258...🥳...WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers, today announced that by decision dated November 8, 2024, the Nasdaq Hearings Panel granted the Company’s request for an extension to evidence compliance with all applicable criteria for continued listing on The Nasdaq Capital Market, including the $1.00 bid price requirement through January 31, 2025 and the $2.5 million stockholders’ equity requirement through February 18, 2025. The Company is considering all available options that may enable it to timely evidence compliance with the continued listing criteria and maintain its listing on Nasdaq; however, there can be no assurance that the Company will be able to do so.

MBIO...266...🥳...https://www.globenewswire.com/news-release/2024/11/07/2976708/0/en/Mustang-Bio-Granted-Orphan-Drug-Designation-by-U-S-FDA-for-MB-108-HSV-1-oncolytic-virus-to-Treat-Malignant-Glioma.html

georgie18

Member Level
Re: georgie18 post# 206

Wednesday, October 30, 2024 12:45:35 PM

Post#
207
of 209
MBIO...33...Added here...Break/Hold .38 and she sees .50plus...imo...we shall see...

georgie18

Member Level
Re: georgie18 post# 662593

Friday, October 25, 2024 2:32:02 PM

Post#
662803
of 663273
MBIO...30s clearing here...🥳...Recent alert at .27 ran to .60 plus range...Break/Hold .37 is what I am looking for...then it should push .50 range...imo...we shall see...
👍️0
georgie18 georgie18 1 mes hace
MBIO...258...🥳...WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers, today announced that by decision dated November 8, 2024, the Nasdaq Hearings Panel granted the Company’s request for an extension to evidence compliance with all applicable criteria for continued listing on The Nasdaq Capital Market, including the $1.00 bid price requirement through January 31, 2025 and the $2.5 million stockholders’ equity requirement through February 18, 2025. The Company is considering all available options that may enable it to timely evidence compliance with the continued listing criteria and maintain its listing on Nasdaq; however, there can be no assurance that the Company will be able to do so.

MBIO...266...🥳...https://www.globenewswire.com/news-release/2024/11/07/2976708/0/en/Mustang-Bio-Granted-Orphan-Drug-Designation-by-U-S-FDA-for-MB-108-HSV-1-oncolytic-virus-to-Treat-Malignant-Glioma.html

georgie18

Member Level
Re: georgie18 post# 206

Wednesday, October 30, 2024 12:45:35 PM

Post#
207
of 209
MBIO...33...Added here...Break/Hold .38 and she sees .50plus...imo...we shall see...

georgie18

Member Level
Re: georgie18 post# 662593

Friday, October 25, 2024 2:32:02 PM

Post#
662803
of 663273
MBIO...30s clearing here...🥳...Recent alert at .27 ran to .60 plus range...Break/Hold .37 is what I am looking for...then it should push .50 range...imo...we shall see...
👍️0
georgie18 georgie18 1 mes hace
MBIO...266...🥳...https://www.globenewswire.com/news-release/2024/11/07/2976708/0/en/Mustang-Bio-Granted-Orphan-Drug-Designation-by-U-S-FDA-for-MB-108-HSV-1-oncolytic-virus-to-Treat-Malignant-Glioma.html

georgie18

Member Level
Re: georgie18 post# 206

Wednesday, October 30, 2024 12:45:35 PM

Post#
207
of 209
MBIO...33...Added here...Break/Hold .38 and she sees .50plus...imo...we shall see...

georgie18

Member Level
Re: georgie18 post# 662593

Friday, October 25, 2024 2:32:02 PM

Post#
662803
of 663273
MBIO...30s clearing here...🥳...Recent alert at .27 ran to .60 plus range...Break/Hold .37 is what I am looking for...then it should push .50 range...imo...we shall see...
👍️0
georgie18 georgie18 2 meses hace
Have a Great Weekend Y'all...🥳
👍️0
georgie18 georgie18 2 meses hace
MBIO...33...Added here...Break/Hold .38 and she sees .50plus...imo...we shall see...

georgie18

Member Level
Re: georgie18 post# 662593

Friday, October 25, 2024 2:32:02 PM

Post#
662803
of 663273
MBIO...30s clearing here...🥳...Recent alert at .27 ran to .60 plus range...Break/Hold .37 is what I am looking for...then it should push .50 range...imo...we shall see...
👍️ 1
georgie18 georgie18 2 meses hace
MBIO...30s clearing here...🥳...Recent alert at .27 ran to .60 plus range...Break/Hold .37 is what I am looking for...then it should push .50 range...imo...we shall see...
👍️ 1
georgie18 georgie18 2 meses hace
MBIO...29s clearing here...🥳
👍️0
georgie18 georgie18 2 meses hace
MBIO...36...HOD...🥳
👍️0
Roadtojourney Roadtojourney 2 meses hace
Some news,
https://www.tipranks.com/news/the-fly/mustang-bio-treatment-of-malignant-glioma-granted-fda-orphan-status?mod=mw_quote_news

👍️0
georgie18 georgie18 2 meses hace
MBIO...61s clearing here...off my .27 Alert...🥳

georgie18

Member Level
Re: georgie18 post# 662291

Tuesday, October 22, 2024 4:39:28 PM

Post#
662292
of 662294
MBIO...43s clearing here...off my .27 Alert...🥳

georgie18

Member Level
Re: georgie18 post# 196

Tuesday, October 22, 2024 4:37:50 PM

Post#
197
of 197
MBIO...34s clearing ...getting some traction here...🥳off the .27 alert...

georgie18

Member Level
Re: georgie18 post# 662019

Tuesday, October 22, 2024 10:35:52 AM

Post#
662172
of 662290
MBIO...318...on the 50ma break...🥳

georgie18

Member Level
Re: None

Monday, October 21, 2024 2:43:46 PM

Post#
195
of 195
MBIO...27s clearing here...🥳...if it can hold the 50ma we can see the .31 Breakout...Psar flipped Bullish...
👍️0
TheFinalCD TheFinalCD 2 meses hace
https://ir.mustangbio.com/news-events

https://dilutiontracker.com/app/search/MBIO?a=dbb88c
👍️0
jwakstock jwakstock 2 meses hace
I knew this was next with all the potential. Possible 500% + coming in the next couple of days.
👍️0
jwakstock jwakstock 2 meses hace
I knew this was next with all the potential. Possible 500% + coming in the next couple of days.
👍️0
georgie18 georgie18 2 meses hace
MBIO...43s clearing here...off my .27 Alert...🥳

georgie18

Member Level
Re: georgie18 post# 196

Tuesday, October 22, 2024 4:37:50 PM

Post#
197
of 197
MBIO...34s clearing ...getting some traction here...🥳off the .27 alert...

georgie18

Member Level
Re: georgie18 post# 662019

Tuesday, October 22, 2024 10:35:52 AM

Post#
662172
of 662290
MBIO...318...on the 50ma break...🥳

georgie18

Member Level
Re: None

Monday, October 21, 2024 2:43:46 PM

Post#
195
of 195
MBIO...27s clearing here...🥳...if it can hold the 50ma we can see the .31 Breakout...Psar flipped Bullish...
👍️0
georgie18 georgie18 2 meses hace
MBIO...34s clearing ...getting some traction here...🥳off the .27 alert...

georgie18

Member Level
Re: georgie18 post# 662019

Tuesday, October 22, 2024 10:35:52 AM

Post#
662172
of 662290
MBIO...318...on the 50ma break...🥳

georgie18

Member Level
Re: None

Monday, October 21, 2024 2:43:46 PM

Post#
195
of 195
MBIO...27s clearing here...🥳...if it can hold the 50ma we can see the .31 Breakout...Psar flipped Bullish...
👍️0
georgie18 georgie18 2 meses hace
MBIO...318...on the 50ma break...🥳

georgie18

Member Level
Re: None

Monday, October 21, 2024 2:43:46 PM

Post#
195
of 195
MBIO...27s clearing here...🥳...if it can hold the 50ma we can see the .31 Breakout...Psar flipped Bullish...
👍️0
georgie18 georgie18 2 meses hace
MBIO...27s clearing here...🥳...if it can hold the 50ma we can see the .31 Breakout...Psar flipped Bullish...
👍️0
motleytool motleytool 5 meses hace
Back in for round 2. Expect a bounce from here.
👍️ 1
Hercules1 Hercules1 6 meses hace
waiting for the next press release to hit.

that will take it to $2.
👍️ 1 🚀 1
SolarRevolution SolarRevolution 6 meses hace
Sure is! Tomorrow should continue the upwards trend towards the $1.40 range!
👍️ 1
glenn1919 glenn1919 6 meses hace
MBIO........................https://stockcharts.com/h-sc/ui?s=MBIO&p=W&b=5&g=0&id=p86431144783
👍️0
Hercules1 Hercules1 6 meses hace
This is due for a massive spike.
👍️0
HeroicCentaur10 HeroicCentaur10 6 meses hace
8000 in my pocket an holding, wish it get to .006 keep talked it down I have 5 years to wait
👍️0
skydog526 skydog526 6 meses hace
4.5 million traded here. If .50 cents will hold, doubtful then peeps can be peeps.
👍️0
Hercules1 Hercules1 6 meses hace
300% to 400% move in a single day is in the cards.

they have the goods.
👍️0
bikaver bikaver 6 meses hace
MBIO.....in @ .4847
👍️0
Hercules1 Hercules1 6 meses hace
Next week should be good for this stock.
👍️0
gail gail 6 meses hace
i see the news now, its on the right side here.
👍️0
gail gail 6 meses hace
stocktwits just said the “offering is closed” so thats good.
👍️0
gail gail 6 meses hace
stocktwits was saying some groups were preparing to squeeze it so, im hopeful.
👍️0
Hercules1 Hercules1 6 meses hace
Hi Gail.

I grabbed a few more also.

Hoping for a big run here.
👍️0
gail gail 6 meses hace
moving up nicely now. looking forward to next week.
👍️0
gail gail 6 meses hace
hi herc.. i grabbed some on the dip here.
👍️0
Hercules1 Hercules1 6 meses hace
You can expect $2 here soon.
👍️0
peterus peterus 6 meses hace
geez you the biggest idiot on ihub
👍️0
eyeownu eyeownu 6 meses hace
Mustang Bio Enters Agreement For Issuance And Sale Of 6.13M Shares At Purchase Price Of $0.41/Share In Registered Direct Offering
👍️0
Hercules1 Hercules1 6 meses hace
get after it ASAP.

attack the dip.

huge opportunity here to score quick 300% gains.

this will blow up this week.

$3 to $4 is not out of the question.
👍️0
Hercules1 Hercules1 6 meses hace
Overall response rate of 90% in cohort with durable responses observed; one patient remains in complete remission at 31 months

All patients were heavily pretreated/refractory to BTK inhibitors, and only one patient has started new anti-WM treatment after MB-106

Outpatient administration was allowed and found to be feasible

Currently no FDA-approved CAR-T treatments for WM

Data presented at the European Hematology Association 2024 Hybrid Congress

WORCESTER, Mass., June 17, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers, today announced that updated data from the ongoing Phase 1/2 clinical trial of MB-106, a CD20-targeted, autologous CAR T-cell therapy, show a favorable safety and efficacy profile in patients with Waldenstrom macroglobulinemia (“WM”), a rare form of blood cancer. MB-106 is being developed in a collaboration between Mustang and Fred Hutch Cancer Center (“Fred Hutch”) to treat patients with relapsed or refractory B-cell non-Hodgkin lymphomas (“B-NHLs”) and chronic lymphocytic leukemia (“CLL”).
👍️0
Hercules1 Hercules1 6 meses hace
expecting this to skyrocket again on thursday morning.
👍️0
Hercules1 Hercules1 6 meses hace
Excellent re-entry point.

This will blow by $2 this week.

👍️0
BigBadWolf BigBadWolf 6 meses hace
why alert while one is loading to dump on his paid subscribers or could it just be as simple as DDAmanda's platform is so outdated & Hans only post after breakouts have already occurred
👍️0
BigBadWolf BigBadWolf 6 meses hace
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174615762
👍️0
peterus peterus 6 meses hace
out 1.20s
👍️0
peterus peterus 6 meses hace
lol realy its up 500%
👍️0
trader59 trader59 6 meses hace
You can't pump this. When they turn their robots off and end the wash trading, those still holding the stock are stuck with heavy bags.
👍️0
Invest-in-America Invest-in-America 6 meses hace
MBIO: This one?? Certainly has at least $2.00 in it for today (IMO).
👍️0
TIMGZ TIMGZ 6 meses hace
AE U STILL WATCHING, OR IN OR OUT OR COMTEMPLATING ON MBIO. WHAT IS YOUR TAKE ON THIS UP AND DOWN JUST LIKE IT DID YESTERDAY
👍️0
peterus peterus 6 meses hace
but hope it will
👍️0
peterus peterus 6 meses hace
dont think so
👍️0
ecmoney ecmoney 6 meses hace
Going to $2


Ec
👍️0

Su Consulta Reciente

Delayed Upgrade Clock